Levalox (Levofloxacin)

Levofloxacin blocks bacterial DNA gyrase and topoisomerase IV, enzymes required for DNA replication and transcription. By preventing these enzymes from separating DNA strands, the drug halts bacterial cell division and leads to bacterial death, providing a bactericidal effect against a wide range of pathogens.

The specific dose of Levalox is determined by the prescribing clinician based on the infection type, severity, patient age, renal function, and other clinical factors. Healthcare professionals follow established guidelines to select the appropriate strength and duration for each individual case.

Safety data for levofloxacin in pregnancy and lactation are limited. The drug is generally avoided unless the potential benefit outweighs the risk to the fetus or infant. Physicians should evaluate the clinical situation and discuss possible alternatives with pregnant or nursing patients.

To request Levalox, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Levalox (levofloxacin) is a third‑generation fluoroquinolone offering once‑daily dosing and a broad spectrum that includes many Gram‑negative and Gram‑positive organisms. Compared with older agents like ciprofloxacin, levofloxacin often provides higher potency against respiratory pathogens and a more convenient dosing schedule, though safety considerations remain similar across the class.

Levalox should be stored at room temperature, below 25 °C, in its original packaging. The container protects the tablets from moisture and light, preserving potency throughout the shelf life. Do not store in humid or excessively hot environments.

Levalox is taken orally, usually as a whole tablet with a full glass of water. It can be taken with or without food, but patients should avoid concurrent intake of antacids containing aluminum or magnesium, as these can reduce absorption. The exact schedule is set by the prescriber.

Serious adverse events linked to levofloxacin include tendon rupture, QT‑interval prolongation leading to cardiac arrhythmias, severe allergic reactions such as anaphylaxis, Clostridioides difficile‑associated colitis, peripheral neuropathy, and rare skin disorders like Stevens‑Johnson syndrome. Prompt medical attention is required if any of these occur.

Levalox is contraindicated in patients with a known hypersensitivity to levofloxacin, other fluoroquinolones, or any component of the formulation. It should also be avoided in individuals with a history of tendon disorders related to fluoroquinolone use, and caution is advised for patients with significant cardiac arrhythmias or prolonged QT interval.